The Pharmaceutical Journal cites Chief Executive

Chief executive of ASH, Deborah Arnott, is quotes in the Pharmaceutical Journal, responding to their story ‘No new licence applications for e-cigarettes since UK medicines regulator changed its guidance’: “Making an application for a medicinal license requires the pulling together of a very detailed dossier which can take significantly longer than six months.” “That no applications have yet been made is no reflection on consumer e-cigarettes currently on the market, which already meet safety standards which are set and overseen by the MHRA [Medicines and Healthcare products Regulatory Agency].”

ASH Chief Executive Deborah Arnott’s response to Philip Morris International’s push towards the cannabis sector, is cited in the Telegraph: “Last August PMI [Philip Morris International] gave a public commitment ‘to operate Vectura as an autonomous business unit”. “Less than nine months later, Vectura and PMI are closely entwined in a joint venture.”

Marking No Smoking Day 2022, ASH chief executive Deborah Arnott was cited in the Northern Echo: “No one should give up on giving up. Every time someone tries to stop smoking, they are a step closer to success. Like anything worth doing it can take practice to stop smoking – but there is lots of help out there. Smokers are three times more likely to succeed in quitting with help from a trained professional than with willpower alone. Healthcare professionals can refer them to this support but smokers can also find their local free service by searching ‘smokefree’ and entering their postcode.”

Chief Executive, Deborah Arnott, and Deputy Chief Executive, Hazel Cheeseman, appeared on Greatest Hits Radio Stations to discuss ASH's Inequalities Dashboard findings.

ASH's analysis of the cost of smoking to society through healthcare, social care and fires were covered in detail in the Mirror.

ASH Chief Executive, Deborah Arnott, responds to the impact of spending cuts and deprivation on the UK government's 2030 smokefree ambition.

Deputy Chief Executive of ASH, Hazel Cheeseman, responds to the news that people with severe asthma and smokers who want to quit, may not get the drugs they need - a broken promise by ministers and the NHS.

Research to mark our 50th anniversary was presented in the Express newspaper with the findings that smoking has claimed 8 million lives in the last 50 years.

Deborah Arnott, Chief Executive of ASH, is quoted in the Financial Times discussing medical licensing for e-cigarettes.

An article discussing the new MHRA guidance on e-cigarette licensing cites YouGov research conducted for ASH showing that the majority of E-cigarette users are current or former smokers.